Overview

Proof of Concept (POC) in Patients With Ischaemic Stroke

Status:
Terminated
Trial end date:
2014-07-28
Target enrollment:
Participant gender:
Summary
Study MAG104615, a Proof of Concept Study for GSK249320 versus placebo in Stroke Patients.
Phase:
Phase 2
Details
Lead Sponsor:
GlaxoSmithKline
Treatments:
Pharmaceutical Solutions